Biocon’s research services arm to set up new plant at Mangalore SEZ

01 Apr 2015 Evaluate

Biocon’s research services arm -- Syngene International -- is planning to set up a new plant at Mangalore SEZ to manufacture pharma ingredients and agro chemicals. In this regard, Syngene International is in the process of acquiring around 40 acres of land on leasehold basis in the multi product category.

The land would be used for setting up commercial scale facilities to manufacture novel active pharmaceuticals ingredients, advance ingredients and agro chemical for Syngene’s client.

Biocon is India’s largest and Asia’s leading biotechnology company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.

 

Biocon Share Price

367.65 -5.00 (-1.34%)
23-Jan-2026 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1631.65
Dr. Reddys Lab 1235.15
Cipla 1314.85
Zydus Lifesciences 885.00
Lupin 2137.15
View more..
Register Now to get our Free Newsletter & much more!

© 2026 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×